Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of New Brunswick

$15,275.00

Enduring sequelae of chronic oral methylphenidate and atomoxetine

EF 2008-09

Résumé
Methylphenidate (MPD) is a stimulant of the central nervous system. Like other drugs of its class (cocaine and amphetamine, for example), MPD can produce lasting changes in the brain when it is administered repeatedly. Recent experiments with rats and mice in this laboratory have found MPD-induced increases in defensive behaviour and impairments of memory formation that persisted well beyond the point when drug administration had ended. In these studies, MPD was delivered orally with food, to mimic the usual manner in which the drug is taken by human recipients. We propose to further explore these phenomena to determine what types of behavioural changes MPD can induce, the influence of age on the development of these changes, and how long these effects will last. Receptor-selective compounds will be used as pharmacological 'probes' that will help to implicate the brain areas that may be involved. Finally, MPD will be compared with a newly marketed drug, atomoxetine, to determine if the latter is less likely to produce the same behavioural consequences. Both compounds are primarily employed clinically in the treatment of attention deficit/hyperactivity disorder (ADHD) in children and adults.
Programme
Discovery Grants Program - Individual
Emplacement
New Brunswick, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
2027-2006
Name nom
Taukulis, Harald
Department département
Psychology (Saint John)
Organization id
75
Institution établissement
University of New Brunswick
Province en
New Brunswick
Province fr
Nouveau-Brunswick
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2006
Award amount
15275
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
12
Committee name en
Psychology: Brain, Behaviour & Cognitive Sciences
Committee name fr
Psychologie: Cerveau, comportement et science cognitive
Area of application code
1210
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Psychology
Area of application fr
Psychologie
Research subject code
6308
Research subject group en
Psychology
Research subject group fr
Psychologie
Research subject en
Behavioural neuroscience
Research subject fr
Neurologie du comportement
Partie
3
Nb partie
5
Application title
Enduring sequelae of chronic oral methylphenidate and atomoxetine
Keyword
NA
Application summary
Methylphenidate (MPD) is a stimulant of the central nervous system. Like other drugs of its class (cocaine and amphetamine, for example), MPD can produce lasting changes in the brain when it is administered repeatedly. Recent experiments with rats and mice in this laboratory have found MPD-induced increases in defensive behaviour and impairments of memory formation that persisted well beyond the point when drug administration had ended. In these studies, MPD was delivered orally with food, to mimic the usual manner in which the drug is taken by human recipients. We propose to further explore these phenomena to determine what types of behavioural changes MPD can induce, the influence of age on the development of these changes, and how long these effects will last. Receptor-selective compounds will be used as pharmacological 'probes' that will help to implicate the brain areas that may be involved. Finally, MPD will be compared with a newly marketed drug, atomoxetine, to determine if the latter is less likely to produce the same behavioural consequences. Both compounds are primarily employed clinically in the treatment of attention deficit/hyperactivity disorder (ADHD) in children and adults.